Search Results 2331-2340 of 18417 for Core activity limitation

  1. A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants with Moderately to Severely Active Crohn's Disease (CD) - Mayo Clinic

    At Week 14 (end of Induction Phase), participants achieving decrease of 70 points in Crohn's Disease Activity ... Serum creatinine > 2 times the upper limit of ...

  2. Established Status Epilepticus Treatment Trial - Mayo Clinic

    The primary outcome measure is cessation of clinical seizure activity ... limitations in the emergency situation. ... Core Facilities · Centers & Programs ...

  3. The Effect of Whole Food Plant-based Diet on Cerebrovascular Reactivity - Mayo Clinic

    More about research at Mayo Clinic. Research Faculty · Laboratories · Core Facilities · Centers & Programs · Departments & Divisions · Clinical Trials ...

  4. Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) - Mayo Clinic

    \[Phase 2 only\] Subject has isolated severe cuffitis without pouch inflammation (endoscopic modified Pouch Disease Activity Index (mPDAI) score of 2 or lower).

  5. Endocrinology - Tests and procedures - Mayo Clinic

    Endocrinology at Mayo Clinic offers treatment and specialty care for people with a wide range of rare and common endocrine disorders.

  6. ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 - Mayo Clinic

    More about research at Mayo Clinic. Research Faculty · Laboratories · Core Facilities · Centers & Programs · Departments & Divisions · Clinical Trials ...

  7. A Pilot Study to Assess the Efficacy of Rituximab Therapy in Treatment Resistant FSGS - Mayo Clinic

    Core Facilities · Centers & Programs · Departments & Divisions · Clinical Trials · Institutional Review Board · Postdoctoral Fellowships · Training Grant ...

  8. A Study Of Clonal Hematopoiesis And Epigenetic Biomarkers Of Biological Aging In Patients With AHCT - Mayo Clinic

    More information. Publications. Publications are currently not available. More about research at Mayo Clinic. Research Faculty · Laboratories · Core Facilities ...

  9. A Study of Exercise Testing and Assessment for Improving Early Identification of Abnormalities of Fontan Circulation, and Early Diagnosis of Fontan Associated Disease (FAD) - Mayo Clinic

    Define and determine the prevalence of pulmonary vascular disease and diastolic dysfunction as assessed by the gold standard of invasive hemodynamic ...

  10. NRG-GY012 “A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, And The Combinations Of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5356 (Capivasertib) In Women With Recurrent, Persistent Or Metastatic Endometrial Cancer. A Multi-Arm Trial For Women With Recurrent Or Persistent Endometrial Cancer” - Mayo Clinic

    Olaparib, cediranib maleate, and Wee1 inhibitor AZD1775 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Participation ...